Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Allied Pain & Spine Institute Now Offering ReNu® Amniotic Suspension Allograft for the Treatment of Osteoarthritis Pain

Allied Pain & Spine Institute
Posted on: 26 Oct 18
Allied Pain & Spine Institute Now Offering ReNu® Amniotic Suspension Allograft for the Treatment of Osteoarthritis Pain Allied Pain & Spine Institute in California now offers a single-injection, regenerative medicine therapy. ReNu is a cryopreserved suspension derived from amniotic tissue and amniotic fluid, formulated for office use.

PR Newswire

SAN JOSE, Calif., Oct. 26, 2018

SAN JOSE, Calif., Oct. 26, 2018 /PRNewswire-PRWeb/ -- Dr. James Petros, Medical Director of Allied Pain & Spine Institute, is pleased to announce ReNu as a new non-surgical treatment option for patients who experience chronic inflammatory and degenerative conditions, such as joint and tendon injuries. It can also be used to support the healing of soft tissues, particularly in degenerative conditions such as osteoarthritis and fasciitis. ReNu is a product from Organogenesis, a leading regenerative medicine company focused on the development, manufacture, and commercialization of solutions for the Advanced Wound Care and Surgical & Sports Medicine markets.

Allied Pain & Spine Institute, located in San Jose, aims to provide effective pain management with a focus on overall patient wellness. This treatment certainly aligns with this mission and brings a number of valued advantages for patients. ReNu is a single-injection therapy that is administered in the office with minimal discomfort and has no repcesareanerse reactions. The tissues in ReNu are collected from scheduled caesarean section births of full-term healthy babies. ReNu delivers anti-inflammatory cytokines and regenerative growth factors and an extracellular matrix content to help treat chronic inflammatory and degenerative conditions, as well as soft tissue injuries. The results of a single ReNu injection may last for up to one year.

"ReNu represents a potentially effective, conservative, and natural approach to osteoarthritis treatment. Most importantly, it is an excellent option for those who want to avoid the regular use of NSAID's or repeated steroid injections to find the relief they need to live an active, pain-free life," says Dr. Petros, founder of Allied Pain & Spine Institute.

More About Dr. James Petros, Medical Director of Allied Pain & Spine Institute:

Dr. James Petros is the founder of Allied Pain & Spine Institute, subspecializing in pain management and musculoskeletal rehabilitation. With his diverse professional and personal backgrounds, Dr. Petros has transcended the science of pain medicine and captured the art of its practice. His integrated approach and balanced understanding of injury and illness are testaments to his unique style. Dr. Petros is an accomplished clinician, researcher, author, and regional speaker in the arenas of injury and functional rehabilitation. He also works with Boston Scientific in the area of pain management.

Dr. Petros reached the culmination of his medical education and training at Stanford University Medical Center, having received numerous honors and awards along his extensive journey. In the course of his budding professional career, Dr. Petros has already gained notable recognitions from America's Top Physicians and the Who's Who registry for his work in pain care and rehabilitation.

To learn more about ReNu treatments or to schedule an appointment with Dr. James Petros, please visit http://www.myalliedpain.com or call one of his office locations in San Jose or Los Gatos, CA.

 

SOURCE Allied Pain & Spine Institute

PR Newswire
www.prnewswire.com

Last updated on: 26/10/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.